{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:49:30Z","timestamp":1777452570640,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.mayocp.2022.12.004","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:04:49Z","timestamp":1680501889000},"page":"631-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Drug-Induced Subcutaneous Sweet Syndrome"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-7790","authenticated-orcid":false,"given":"Yi-Teng","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yau-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2022.12.004_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet syndrome: a review and update","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.004_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.det.2008.06.003","article-title":"Subcutaneous sweet syndrome","volume":"26","author":"Guhl","year":"2008","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.004_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/1346-8138.12430","article-title":"Case of vemurafenib-induced Sweet's syndrome","volume":"41","author":"Yorio","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.12.004_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cup.12149","article-title":"Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib","volume":"40","author":"Kim","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.004_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaad.2020.04.105","article-title":"Dermatologic toxicities to immune checkpoint inhibitor therapy: a review of histopathologic features","volume":"83","author":"Ellis","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:40:26Z","timestamp":1758418826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622006978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0025619622006978"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.12.004","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Subcutaneous Sweet Syndrome","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}